Completed OBSERVATIONAL NCT04001257

18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma (GLIOFET)

Role of 18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) for Grading Glioma

Sponsor: University Hospital, Brest

Conditions Glioma Positron Emission Tomography

Updated 5 times since 2019 Last updated: Jan 14, 2020 Started: Jun 17, 2019 Primary completion: Sep 17, 2019 Completion: Sep 17, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Glioma and Positron Emission Tomography, this trial is completed. The trial is conducted by University Hospital, Brest and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Feb 2020 — Jan 2021 [monthly]

Completed

Status: Recruiting → Completed
Jul 2019 — Feb 2020 [monthly]

Recruiting

First recorded

Jun 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Brest

Data source: University Hospital, Brest

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brest, France